Muscular Dystrophy, Becker Clinical Trials
2 recruiting trials for Muscular Dystrophy, Becker. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Muscular Dystrophy, Becker clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Assistance Publique - Hôpitaux de Paris (1), Assistance Publique Hopitaux De Marseille (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Blood sample (biological, 1 trial), followed by ARN extraction from muscle biopsies.
Track Muscular Dystrophy, Becker trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Cell-free fetal DNA (cffDNA) is present in the maternal blood from the early first trimester of gestation and makes up 5%-20% of the total circulating cell-free DNA (cfDNA) in...
Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases
Since 2017, more than 250 analyses performed at the Molecular Genetics Laboratory of the Timone Enfant Hospital have yielded negative results in patients with rare genetic muscle...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Muscular Dystrophy, Becker, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Muscular Dystrophy, Becker, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Muscular Dystrophy, Becker, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.